CHINOOK THERAPEUTICS INC (KDNY) Earnings History & Surprises

NASDAQ:KDNYUS16961L1061

Current stock price

40.39 USD
+0.09 (+0.22%)
At close:
40.32 USD
-0.07 (-0.17%)
After Hours:

KDNY Earnings overview

Past quarterly earnings results for CHINOOK THERAPEUTICS INC (KDNY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 8, 2023
Period
Q3 / 2023
EPS Estimate
-$0.83
Revenue Estimate
255K

Last Reported

Most Recent
Release Date
Aug 7, 2023
Period
Q2 / 2023
EPS Reported
-$0.94
EPS Surprise
-13.35%
Revenue Surprise
311.76%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2023 -0.94 -0.83 -13.35% -54.10% 1.008M 244.8K 311.76% 141.15%
Q1 2023 -0.85 -0.81 -4.85% -57.41% 1.828M 244.8K 646.73% -32.22%
Q4 2022 -0.90 -0.81 -11.69% -742.86% 512K 102K 401.96% -99.00%
Q3 2022 -0.83 -0.64 -30.05% -20.29% 2.501M 102K 2,351.96% 62,425.00%
Q2 2022 -0.61 -0.63 2.49% 46.49% 418K 425.003K -1.65% 1,129.41%
Q1 2022 -0.54 -0.68 20.51% 38.64% 2.697M - 670.57%
Q4 2021 0.14 -0.69 120.30% 111.29% 51.236M - 327.92%
Q3 2021 -0.69 -0.86 19.31% 23.33% 4K 42.503K -90.59% -99.89%
Q2 2021 -1.14 -0.80 -42.68% -8.57% 34K 42.503K -20.01% -99.39%
Q1 2021 -0.88 -0.69 -27.50% -95.56% 350K 51K 586.27% -97.49%
Q4 2020 -1.24 -0.45 -173.19% - -22.48M 2.525M -990.30% -
Q3 2020 -0.90 -0.46 -93.92% - 3.79M 3.91M -3.07% -
Q2 2020 -1.05 -0.97 -8.36% - 5.57M 3.523M 58.10% -
Q1 2020 -0.45 -0.69 34.64% - 13.95M 10.705M 30.31% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

KDNY EPS Q2Q GrowthKDNY EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 0 -200 -400 -600

Revenue Historical Q2Q growth and Acceleration

KDNY Revenue Q2Q GrowthKDNY Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q4/25 0 20K 40K 60K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
0
Average EPS beat (4)
-14.99%
Max EPS beat (4)
-4.85%
Min EPS beat (4)
-30.05%

Revenue beat statistics

Revenue beat (4)
4
Average Revenue beat (4)
928.11%
Max Revenue beat (4)
2,351.96%
Min Revenue beat (4)
311.77%

Analysis

In the last 4 quarters, KDNY has not beaten EPS estimates in any release
KDNY has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, KDNY reported -15.0% below the EPS estimates on average.
In the last 4 quarters, KDNY has beaten the revenue estimates by 928.1% on average.

CHINOOK THERAPEUTICS INC / KDNY Earnings FAQ

Can you provide the last earnings date for CHINOOK THERAPEUTICS INC?

CHINOOK THERAPEUTICS INC (KDNY) last reported earnings on 8/7/2023.

Did CHINOOK THERAPEUTICS INC (KDNY) beat earnings estimates last quarter?

CHINOOK THERAPEUTICS INC (KDNY) missed EPS estimates and beat revenue estimates in the most recent quarter.

What percentage of the time does KDNY stock beat earnings estimates?

In the last 4 quarters, CHINOOK THERAPEUTICS INC (KDNY) has beaten EPS estimates in 0 out of 4 releases.